No Data
No Data
Prime Medicine (PRME) Gains 16.4% in 3 Months: Buy Now or Wait?
Lexeo Stock Drops 24% Amid Friedreich Ataxia Study Results
Prime Medicine, Inc. (PRME): Why Do Analysts Love This Shorted Stock Right Now?
Wall Street Analysts Believe Prime Medicine, Inc. (PRME) Could Rally 120.95%: Here's Is How to Trade
Prime Medicine to Present at Upcoming Investor Conferences
PDF Version CAMBRIDGE, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curati
GFS, PETS and CYTK Are Among After Hour Movers